Australia's largest stock trading and investment forum Australia's #1 stock forum

BGT

7.27%

5.1¢ bio-gene technology ltd

Ann: Appendix 3Ys, page-20

First 20 Last

Share
Profile

Follow
stormer

17,965 Posts.

1659

26/12/19

13:59

Post #: 42130669
Share

Originally posted by kellbys: ↑

Think those making a mountain out of a mole hill need to get a grip and put things into perspective here!

Both of these directors still hold a very substantial amount of shares in BGT, which they've held since the Company was listed.

Richard Jagger:-

Sold 316,927 short term incentive shares.

No. of securities held after change Direct: 3,852,266 ordinary shares. Indirect: 65,000 ordinary shares

Peter May:-

Sold 46,895 short term incentive shares

No. of securities held after change Direct: 1,472,427 ordinary shares. Indirect: 331,000 ordinary shares.

• Richard Jagger and Peter May have no plans to sell any further shares in Bio-Gene.Share price goes to a $1.00 and they're both millionaires....

Expand

Spot on Kellbys...if they wanted to cash out in the recent run up, they would have sold a decent amount of shares..they sold a fraction of their holdings to cover a liability

Almost as big a beat up as Scomo going on holiday

BGT Price at posting: 20.0¢ Sentiment: Hold Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

BUX

Buxton projects new graphite province discovery at WA Narryer play

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

There are more pages in this discussion • 2 more messages in this thread...

First 20 Last

Add BGT (ASX) to my watchlist

(20min delay)
Last 5.1¢		Change -0.004(7.27%)		Mkt cap ! $10.26M

Open	High	Low	Value	Volume
5.1¢	5.1¢	5.1¢	$357	7K

Buyers (Bids)

No.	Vol.	Price($)
1	65600	5.1¢

Sellers (Offers)

Price($)	Vol.	No.
6.0¢	100000	1

View Market Depth

No.	Vol.	Price($)
1	65600	0.051
2	30093	0.048
1	112000	0.045
1	596	0.044
1	33333	0.043

Price($)	Vol.	No.
0.060	100000	1
0.067	10761	1
0.070	57400	1
0.073	8685	1
0.075	42000	1

Last trade - 15.05pm 04/10/2024 (20 minute delay)

BGT (ASX) Chart

Ann: Appendix 3Ys, page-20

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Appendix 3Ys, page-20

Top Stories

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Buxton projects new graphite province discovery at WA Narryer play

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BCI reaches close of funding facility for salt-first part of Mardie project

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News